GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Acorda Therapeutics, Inc. (ACOR) [hlAlert]

Acorda Therapeutics is commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury
and other disorders of the central nervous system. Acorda currently markets Zanaflex Capsules for the management of spasticity. The Company's lead product candidate, Fampridine-SR, for the improvement of walking ability in persons with multiple sclerosis. It develops therapies that restore neurological function to people with spinal cord injury, multiple sclerosis and related conditions of the nervous system.
( Total: 22 Current Stock Recommendations )
Acorda Therapeutics, Inc.   (22)
Sell Hold 18% Buy 73%
Related companies
China Biologic ...   (4)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Flamel Technologies ...   (8)
Buy 100%
Aeterna Zentaris, ...   (12)
Buy 100%
Lannett Co Inc   (4)
Buy 100%
Anika Therapeutics ...   (4)
Buy 100%
Emergent ...   (6)
Buy 100%
Insys Therapeutics ...   (4)
Buy 100%
Filter by Gains:   
  
Rating:
Buy ACOR
down 17.58 %

Rating:
Hold ACOR

Rating:
Buy ACOR
down 0.03 %

Rating:
Hold ACOR
up 3.86 %

Rating:
Hold ACOR
up 20.78 %

Rating:
Buy ACOR
up 3.15 %

Rating:
Hold ACOR

Rating:
Buy ACOR
down 6.87 %

Rating:
Buy ACOR
down 15.78 %

Rating:
Sell ACOR
up 20.78 %

Rating:
Hold ACOR

Rating:
Buy ACOR
down 6.87 %

Rating:
Hold ACOR
up 1.16 %

Rating:
Buy ACOR
up 3.86 %
Acorda Therapeutics, Inc. (ACOR) upgraded to Buy by Citigroup
Thursday,  Jan 3, 2013  8:25 AM ET

Rating:
Buy ACOR
up 27.78 %

Your Recent Stocks
SymbolLastChange
ACOR 25.87 down  -18.36 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy